Peng et al. indicated that in patients with gastrointestinal cancers (colorectal cancer, esophageal cancer, and gastric cancer) receiving anti-PD-1/PD-L1 treatment, the relative abundance of Lachnospiraceae was significantly higher in responders than in non-responders. Here, PDCD1 is linked to gastric cancer.